Page 22 - Gene Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AusBiotech is seeking feedback from Members on proposed changes to the Gene Technology Scheme (the Scheme) that may impact companies and early research...

Credit: Tõnu Tuulas Multiple sclerosis (MS) is the most common neurological disease in young adults, affecting more than 2 million individuals worldwide, with about 1500 cases in Estonia. About 20% of MS patients experience optic neuritis (ON) as the presenting symptom, but not all ON patients develop MS. The TalTech gene technology research unit, in collaboration with the laboratory of Protobios OÜ and medical researchers of the University of Helsinki, published their findings in the prestigious journal of EBioMedicine entitled "Identification of two highly antigenic epitope markers predi...

Potential GMO research misconduct at Norway's Institute of Marine Research Details Did scientists break the law by eating GMO salmon from their research project? Report: Claire Robinson A researcher at Norway's Institute of Marine Research has reportedly committed GMO research misconduct, according to a news article published by the Norwegian National Research Ethics Committees.   According to the article, Anna Wargelius killed and ate GMO CRISPR gene-edited salmon from the research project that she leads, claiming it was "safe" to do so. Her unnamed colleagues on ...

SARS-CoV-2 Real-Time RT-PCR Assay The PerkinElmer SARS-CoV-2 Real-Time RT-PCR assay is CE-IVD (in vitro diagnostic) marked and intended for qualitative detection of nucleic acid from the SARS-CoV-2 virus in human oropharyngeal swab, nasopharyngeal swab, and saliva specimens from individuals suspected of having COVID-19 or from asymptomatic carriers. The assay target two specific genomic regions of SARS-CoV-2: the nucleocapsid (N) gene and ORF1ab; so mutations in spike protein, as seen in the B.1.1.7 and B.1.351 coronavirus lineages, do not impact the safety and effectiveness of PerkinElmer's ...

New gene therapy can reverse some of effects of ageing in mice and extend their lifespans Reuters January 20, 2021 Dr Shuhui Sun performs a step of histological staining of mouse liver for pathological analysis in the Aging and Regeneration lab at the Institute for Stem Cell and Regeneration of the Chinese Academy of Sciences (CAS) in Beijing, China, January 12, 2021. Picture taken January 12, 2021. PHOTO: REUTERS BEIJING: Scientists in Beijing have developed a new gene therapy which can reverse some of the effects of ageing in mice and extend their lifespans, findings which may one day con...